Yukiko Mori

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda et al. · Journal of Clinical Oncology · 2015 · 1.2K citations

Medicine, Oncology, Pharmacology +17

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

Masashi Kanai, Kenichi Yoshimura, Masanori Asada et al. · Cancer Chemotherapy and Pharmacology · 2010 · 398 citations · Full text

Medicine, Oncology, Pharmacology +10

Mycolic Acid-Containing Bacteria Induce Natural-Product Biosynthesis in <i>Streptomyces</i> Species

Hiroyasu Onaka, Yukiko Mori, Yasuhiro Igarashi et al. · Applied and Environmental Microbiology · 2010 · 270 citations · Full text

Life Sciences, Microbiology, Microbial Metabolism +12

A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients

Masashi Kanai, Yoshihiko Otsuka, Kazunori Otsuka et al. · Cancer Chemotherapy and Pharmacology · 2013 · 191 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Infiltration of Neutrophils Is Required for Acquisition of Metastatic Phenotype of Benign Murine Fibrosarcoma Cells

Hiroshi Tazawa, Futoshi Okada, Tokushige Kobayashi et al. · American Journal Of Pathology · 2003 · 177 citations · Full text

Medicine, Cancer Biology, Oncology +16